Ami Fadia
Stock Analyst at Needham
(3.45)
# 942
Out of 4,858 analysts
422
Total ratings
45.97%
Success rate
4.38%
Average return
Main Sectors:
Stocks Rated by Ami Fadia
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PRAX Praxis Precision Medicines | Reiterates: Buy | $80 | $44.60 | +79.39% | 12 | Jun 12, 2025 | |
| BIIB Biogen | Reiterates: Hold | n/a | $133.06 | - | 41 | Jun 12, 2025 | |
| JAZZ Jazz Pharmaceuticals | Reiterates: Buy | $202 | $110.50 | +82.81% | 32 | Jun 11, 2025 | |
| AXSM Axsome Therapeutics | Maintains: Buy | $153 → $150 | $108.08 | +38.79% | 15 | Jun 9, 2025 | |
| IMRX Immuneering | Reiterates: Buy | $9 | $2.12 | +324.53% | 16 | Jun 5, 2025 | |
| BPMC Blueprint Medicines | Downgrades: Hold | $130 | $127.95 | +1.60% | 31 | Jun 2, 2025 | |
| CNTA Centessa Pharmaceuticals | Initiates: Buy | $35 | $12.47 | +180.67% | 1 | May 28, 2025 | |
| ALKS Alkermes | Initiates: Buy | $45 | $31.20 | +44.23% | 1 | May 28, 2025 | |
| MRUS Merus | Maintains: Buy | $75 → $88 | $55.05 | +59.85% | 29 | May 23, 2025 | |
| ACAD ACADIA Pharmaceuticals | Maintains: Buy | $27 → $30 | $22.30 | +34.53% | 9 | May 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $5 | $0.92 | +442.48% | 9 | May 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $57 | $40.79 | +39.74% | 23 | May 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $19 | $9.89 | +92.11% | 36 | May 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $30 → $27 | $6.75 | +300.00% | 20 | May 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $49 | $35.14 | +39.44% | 37 | May 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $138 → $139 | $124.17 | +11.94% | 14 | May 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $29 | $8.76 | +231.05% | 20 | May 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $6.77 | - | 21 | Apr 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $7.26 | - | 22 | Feb 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $240 → $320 | $13.25 | +2,315.09% | 2 | Feb 1, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | $63 → $75 | $24.34 | +208.13% | 7 | Jan 21, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $15 → $23 | $1.04 | +2,063.46% | 4 | Oct 1, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $64 → $63 | $27.37 | +130.18% | 5 | Sep 17, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | $12 → $5 | $4.08 | +22.55% | 2 | Jan 30, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Market Perform | n/a | $17.32 | - | 9 | Oct 1, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $22 | $2.06 | +967.96% | 4 | Jan 3, 2018 |
Praxis Precision Medicines
Jun 12, 2025
Reiterates: Buy
Price Target: $80
Current: $44.60
Upside: +79.39%
Biogen
Jun 12, 2025
Reiterates: Hold
Price Target: n/a
Current: $133.06
Upside: -
Jazz Pharmaceuticals
Jun 11, 2025
Reiterates: Buy
Price Target: $202
Current: $110.50
Upside: +82.81%
Axsome Therapeutics
Jun 9, 2025
Maintains: Buy
Price Target: $153 → $150
Current: $108.08
Upside: +38.79%
Immuneering
Jun 5, 2025
Reiterates: Buy
Price Target: $9
Current: $2.12
Upside: +324.53%
Blueprint Medicines
Jun 2, 2025
Downgrades: Hold
Price Target: $130
Current: $127.95
Upside: +1.60%
Centessa Pharmaceuticals
May 28, 2025
Initiates: Buy
Price Target: $35
Current: $12.47
Upside: +180.67%
Alkermes
May 28, 2025
Initiates: Buy
Price Target: $45
Current: $31.20
Upside: +44.23%
Merus
May 23, 2025
Maintains: Buy
Price Target: $75 → $88
Current: $55.05
Upside: +59.85%
ACADIA Pharmaceuticals
May 19, 2025
Maintains: Buy
Price Target: $27 → $30
Current: $22.30
Upside: +34.53%
May 13, 2025
Reiterates: Buy
Price Target: $5
Current: $0.92
Upside: +442.48%
May 8, 2025
Reiterates: Buy
Price Target: $57
Current: $40.79
Upside: +39.74%
May 8, 2025
Reiterates: Buy
Price Target: $19
Current: $9.89
Upside: +92.11%
May 7, 2025
Maintains: Buy
Price Target: $30 → $27
Current: $6.75
Upside: +300.00%
May 7, 2025
Reiterates: Buy
Price Target: $49
Current: $35.14
Upside: +39.44%
May 6, 2025
Maintains: Buy
Price Target: $138 → $139
Current: $124.17
Upside: +11.94%
May 2, 2025
Reiterates: Buy
Price Target: $29
Current: $8.76
Upside: +231.05%
Apr 30, 2025
Reiterates: Hold
Price Target: n/a
Current: $6.77
Upside: -
Feb 26, 2025
Reiterates: Hold
Price Target: n/a
Current: $7.26
Upside: -
Feb 1, 2021
Maintains: Outperform
Price Target: $240 → $320
Current: $13.25
Upside: +2,315.09%
Jan 21, 2021
Downgrades: Market Perform
Price Target: $63 → $75
Current: $24.34
Upside: +208.13%
Oct 1, 2020
Maintains: Market Perform
Price Target: $15 → $23
Current: $1.04
Upside: +2,063.46%
Sep 17, 2020
Maintains: Outperform
Price Target: $64 → $63
Current: $27.37
Upside: +130.18%
Jan 30, 2019
Downgrades: Market Perform
Price Target: $12 → $5
Current: $4.08
Upside: +22.55%
Oct 1, 2018
Upgrades: Market Perform
Price Target: n/a
Current: $17.32
Upside: -
Jan 3, 2018
Initiates: Outperform
Price Target: $22
Current: $2.06
Upside: +967.96%